📰 Trial Application News
Page 2 - Trial Application News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Trial Application. Real-time updates on events, politics, business and more.
May 16, 2022
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
March 30, 2022
Taysha Gene Therapies Announces Initiation of Clinical Development of TSHA-102 in Rett Syndrome
March 28, 2022
/PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics...
February 16, 2022
CASI PHARMACEUTICALS ANNOUNCES PRELIMINARY FOURTH QUARTER AND FULL-YEAR 2021 REVENUES AND PROVIDES BUSINESS UPDATES Expects to Report EVOMELA® Fourth Quarter 2021 Unaudited... | February 16, 2022
December 14, 2021
Press release content from Business Wire. The AP news staff was not involved in its creation.
November 30, 2021
Dublin, Nov. 30, 2021 (GLOBE NEWSWIRE) -- The "U.S. Medical Device Outsourcing Market Size, Share & Trends Analysis & Forecasts 2021" report has...
November 30, 2021
/PRNewswire/ -- The "U.S. Medical Device Outsourcing Market Size, Share & Trends Analysis & Forecasts 2021" report has been added to ResearchAndMarkets.coms...
November 30, 2021
/PRNewswire/ -- The "U.S. Medical Device Outsourcing Market Size, Share & Trends Analysis & Forecasts 2021" report has been added to ResearchAndMarkets.coms...
August 10, 2021
ACTengine patient recruitment remains on track; as of end of July, a total of 27 patients have been treated with IMA201, IMA202 or IMA203 across different cancer indicationsTCR Bispecifics pipeline
April 12, 2021
Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone for COVID-19 Resverlogix Plans to Emulate the Pfizer and Moderna Models of Rapid Parallel Development use April 12, 2021 08:00 ET | Source: Resverlogix Corp Resverlogix Corp Calgary, Alberta, CANADA CALGARY, Alberta, April 12, 2021 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix") (TSX:RVX) is pleased to announce that it has successfully...